News Focus
News Focus
icon url

flipper44

11/23/24 11:38 AM

#733652 RE: ATLnsider #733650

Yes, but the maturation portion is discussed in the other nearby sections of the 10Q. So if it’s not BCG that portion will likely be poly-iclc, which also can boost the immune system when used as an adjuvant.

In other words, I think we are in agreement.
icon url

XMaster2023

11/23/24 11:45 AM

#733656 RE: ATLnsider #733650

ATL/Flip-
If Flippers and your assumptions are correct, Flaskworks and DCVax-L/D and XPoly ICLC and X (Keytruda or ?) will soon be going through short clinical trials?
icon url

manibiotech

11/23/24 11:58 AM

#733657 RE: ATLnsider #733650

Which no one cares about . Only way the SP will go up is with approval and some deal involving large upfront cash . Science project days are long gone .